Skip to main content Skip to main navigation menu Skip to site footer
Reumatismo - The Italian Journal of Rheumatology

eISSN 2240-2683

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Early Access
  • Archives
  • Special Issues
    • Overview
  • Register
  • Login
  • Search
  • Contacts
  • News

Editor-in-Chief: M.A. Cimmino, Genova, Italy

1.0
Impact Factor 2024
1.7
CiteScore 2024
1.0
Impact Factor 2024
1.7
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression, a marker of platelet activation

    A. Bontadi, A. Ruffatti, S Giannini, E. Falcinelli, M. Tonello, A. Hoxha, P. Gresele, L. Punzi
    35-39
    19-03-2012
    https://doi.org/10.4081/reumatismo.2012.35
    1654
    PDF: 683
  • The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

    M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani
    137-143
    16-12-2016
    https://doi.org/10.4081/reumatismo.2016.891
    2296
    PDF: 1376
  • Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease

    S. Piantoni, L. Andreoli, F. Allegri, P.L. Meroni, A. Tincani
    307-313
    11-12-2012
    https://doi.org/10.4081/reumatismo.2012.307
    2458
    PDF: 1224
  • Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus

    L. Iaccarino, A. Ghirardello, M. Zen, D. Villalta, A. Tincani, L. Punzi, A. Doria
    314-320
    11-12-2012
    https://doi.org/10.4081/reumatismo.2012.314
    2565
    PDF: 1302
  • The history of antiphospholipid syndrome

    A. Tincani, G. Fontana, C. Mackworth-Young
    21-03-2023
    https://doi.org/10.4081/reumatismo.2022.1556
    2692
    PDF: 2380
  • PO:15:221 | Proteins upregulated in thrombotic antiphospholipid syndrome link to platelet function in contrast with non-antiphospholipid-related thrombosis: insights from two systematic reviews Silvia Mancuso1, Claudia Ciancarella1, Luca Rapino1, Simona Truglia1, Cristiano Alessandri1, Fabrizio Conti1. | 1Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari - Rheumatology Unit, Sapienza Univers, Roma, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2041
    20
  • Peripheral neuropathy in antiphospholipid syndrome: a systematic review

    Rafael Reis do Espírito Santos, Cezar Augusto Muniz Caldas, Jozélio Freire de Carvalho
    03-06-2025
    https://doi.org/10.4081/reumatismo.2025.1735
    2358
    PDF: 89
  • PO:14:205 | Primary antiphospholipid antibody syndrome: association between new classification criteria manifestations and a higher-risk disease phenotype Sara Ferrigno1, Vittorio Forte2, Marco Panetta1, Sergio Lisena1, Giorgia Ranucci2, Luigi De Marco1, Elisabetta Greco1, Alberto Bergamini1, Maria Sole Chimenti1, Paola Conigliaro1. | 1Rheumatology, allergology and clinical immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 2Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2034
    19
  • The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review

    Liala Moschetti, Francesca Crisafulli, Francesca Regola, Rossana Orabona, Sofia Pitsigavdaki, Franco Franceschini, Laura Andreoli, Sonia Zatti, Angela Tincani
    29-07-2025
    https://doi.org/10.4081/reumatismo.2025.1835
    959
    PDF: 19
  • Adrenal hemorrhage and non-ST elevation myocardial infarction: an antiphospholipid syndrome dilemma

    G. El Hasbani, M. Del Pilar Morel, B. Tandoh, J.F. Vargas, R. Crusio
    18-09-2023
    https://doi.org/10.4081/reumatismo.2023.1584
    1275
    PDF: 777
  • Primary antiphosholipid syndrome and hyperomocysteinemia: a study of a group of 29 patients

    T. Del Ross, A. Ruffatti, M. Tonello, G. Salmistraro, A. Calligaro, M. Favaro, M. Ciprian, S. Todesco
    283-287
    https://doi.org/10.4081/reumatismo.2006.283
    977
    PDF: 1113
  • PO:26:095 | Educational online webinars of European Reference Network on rare and complex connective tissue and musculoskeletal diseases for patients, caregivers and healthcare professionals: six years' experience Emanuele Gotelli1|2, Rosanna Campitiello1|3, Eric Hachulla4|5|6, Vanessa Smith7|8|9, Joao Eurico Fonseca10|11, Tadej Avcin12|13, Gabriele Simonini14|15, Silvia Aguilera16, Lisa Matthews17, Charissa Frank18, Wiebke Lautré19, Monica Testoni20, Diana Marinello20, Rosaria Talarico20, Marta Mosca20, Maurizio Cutolo1|2. | 1Department of Internal Medicine and Specialties, University of Genova, Genova, Italy; 2IRCCS Ospedale Policlinico San Martino, Genova, Italy; 3Department of Experimental Medicine DIMES, University of Genova, Genova, Italy; 4Institute for Translational Research in Inflammation INFINITE, Université de Lille, Lille, France; 5INSERM, Lille, France; 6Centre de référence des maladies autoimmunes systemiques rares du Nord et Nord-Ouest de France CeRAINO, Lille, France; 7Department of Internal Medicine, University of Ghent, Ghent University Hospital, Ghent, Belgium; 8Department of Rheumatology, University of Ghent, Ghent University Hospital, Ghent, Belgium; 9Unit for Molecular Immunology and Inflammation, Flemish Institute for Biotechnology, Inflammation Research Center, Ghent, Belgium; 10Centro Hospitalar Universitário Lisboa Norte EPE, Serviço de Reumatologia e Doenças Ósseas Metabólicas Lisboa Portugal; 11Universidade de Lisboa, Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular João Lobo Antunes Lisboa Portugal; 12University Children Hospital, University Medical Center Ljubljana, Ljubljana, Slovenia; 13University of Ljubljana, Department of Paediatrics, Ljubljana, Slovenia; 14University of Florence, NEUROFARBA Department, Firenze, Italy; 15Meyer Children Hospital IRCCS, Rheumatology Unit, Firenze, Italy; 16Spanish Association for Antiphospholipid Syndrome, Elche, Spain; 17Relapsing Polychondritis Awareness and Support, Worcester, United Kingdom; 18Flemish Association for Hereditary Connective Tissue Disorders, Koersel, Belgium; 19CHU Bordeaux Pellegrin, Centre de Références Maladies Auto-Immunes Systémiques Rares, Bordeaux, France; 20Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2066
    15
  • Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies

    S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti
    25-09-2024
    https://doi.org/10.4081/reumatismo.2024.1701
    1005
    PDF: 297
  • Confirmation of antiphospholipid antibody positivity: a year’s results in a cohort of 113 patients

    S. Cuffaro, T. Del Ross, M. Tonello, A. Bontadi, S. Olivieri, E. Salvan, A. Ruffatti, L. Punzi
    51-59
    https://doi.org/10.4081/reumatismo.2010.51
    1432
    PDF: 785
  • Laboratory diagnosis of antiphospholipid syndrome

    V. Pengo, A. Ruffatti
    187-191
    https://doi.org/10.4081/reumatismo.2007.187
    828
    PDF: 813
  • Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

    C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani
    91-96
    https://doi.org/10.4081/reumatismo.2011.91
    1328
    PDF: 776
  • Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome

    V. Bruzzese, P. Scolieri, J. Pepe
    07-02-2022
    https://doi.org/10.4081/reumatismo.2021.1431
    5820
    PDF: 708
  • PO:10:149 | Efficacy of anifrolumab in a case of systemic lupus erythematosus with pulmonary involvement Fabio Brandolino1, Giulia Pazzola1, Luca Ronzoni3, Andreina Teresa Manfredi1|2, Carlo Salvarani1|2 | 1SC Reumatologia, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia; 2Università di Modena e Reggio Emilia, Scuola di specializzazione in Reumatologia, Modena; 3SC Malattie dell'Apparato Respiratorio, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2146
    18
  • Catastrophic antiphospholipid syndrome as a complication of systemic sclerosis

    D.J. Manzella, L. Vicente, A.A. Pérez de la Hoz, R.J. Zamora, G. De Rosa, A.A. Pisarevsky
    92-98
    09-07-2019
    https://doi.org/10.4081/reumatismo.2019.1095
    1477
    PDF: 1065
  • Sensibility and specificity for pregnancy morbidity of anti-b2-glycoprotein I antibodies in antiphospholipid syndrome

    M. Tonello, A. Ruffatti, M. Favaro, T. Del Ross, D. Zamboni, P. Grypiotis, A. Cavazzana, M. Ciprian, S. Todesco
    262-266
    https://doi.org/10.4081/reumatismo.2005.262
    1148
    PDF: 1064
  • Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?

    L. Andreoli, F. Pregnolato, R.W. Burlingame, V. Fanelli, F. Allegri, A. Radice, C. Corace, R.A. Sinico, A. Tinconi, P.L. Meroni
    185-191
    https://doi.org/10.4081/reumatismo.2008.185
    1170
    PDF: 1112
  • Role of anti-prothrombin in antiphospholipid syndrome

    M. Cinquini, M. Vianelli, F. Allegri, R. Cattaneo, G. Balestrieri, A. Tincani
    243-250
    https://doi.org/10.4081/reumatismo.2002.243
    846
    PDF: 1356
  • Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with reumatic diseases

    P. Grypiotis, A. Ruffatti, M. Tonello, C. Winzler, C. Radu, S. Zampieri, M. Favaro, A. Calligaro, S. Todesco
    232-237
    https://doi.org/10.4081/reumatismo.2002.232
    1706
    PDF: 5963
  • Multiple Sclerosis and autoimmune diseases: clinical cases and review of the literature

    G. Castellino, A. Protti, B. Canesi
    196-203
    https://doi.org/10.4081/reumatismo.2001.196
    1028
    PDF: 5293
  • PO:17:253 | Unveiling the gap: a multicenter study on factors driving patient-physician discrepancies in assessing disease activity in systemic lupus erythematosus Giorgia Ingrid Gozzoli1, Micaela Fredi1, Federica Bonaso1, Silvia Ebe Lucia Della Pina1, Claudia Barison1, Irene Lorenzini4, Raffaele Pericotti4, Anna Mattiuzzo4, Marcelo Neto2, Sofia Azevedo3, Cláudia Oliveira3, Cesare Tomasi4, Luís Sousa Inês2, Franco Franceschini1. | 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy; 2Rheumatology Department, Centro Hospitalar Universitário de Coimbra - ULS Coimbra, Coimbra, Portugal; 3Rheumatology  Department, ULS Aveiro, Aveiro, Portugal; 4Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2046
    18
  • PO:12:178 | Don't count your chickens before they hatch! Analysis of cardiovascular definitions in studies on rheumatic diseases: a systematic literature review Laura Pezzoni1, Silvia Sirotti1|2, Georgios Filippou1|2, Piercarlo Sarzi Puttini1|2, Greta Pellegrino1|2. | 1Università degli Studi di Milano, Milano; 2IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2028
    20
  • Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome

    S. Olivieri, A. Ruffatti, A. Bontadi, A. Cavazzana, E. Salvan, S. Cuffaro, S. Giunco, L. Punzi
    107-112
    https://doi.org/10.4081/reumatismo.2010.107
    1279
    PDF: 726
  • CO:11:5 | Laboratory preliminary results from an open label, prospective, phase ii descriptive pilot trial of belimumab therapy for refractory and/or non criteria manifestations of antiphospholipid syndrome Alice Barinotti1, Massimo Radin1, Irene Cecchi1, Beatrice Ala1, Chiara Raymondi1, Elena Rubini1, Silvia G. Foddai1, Lois Ira Maniulit Capulong1, Alessio Conti1, Alessandro Morotti1, Dario Roccatello1, Roberta Fenoglio1, Savino Sciascia1. | 1Università di Torino, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.1997
    20
  • Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I

    L. Andreoli, C. Nalli, M. Motta, G.L. Norman, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, T. Avcin, P.L. Meroni, A. Tincani
    189-194
    https://doi.org/10.4081/reumatismo.2010.189
    1084
    PDF: 657
  • CO:11:2 | Systemic lupus erythematosus with major neuropsychiatric involvement treated with anifrolumab: literature review and a case report Giulia Rizzo1, Fabio Congiu1, Elisabetta Chessa2, Marta Paola Pireddu1, Elena Ragusa1, Alessandra Oliva1, Marianna Salis1, Alberto Cauli1|2, Matteo Piga1|2 | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari Italy; 2SC Reumatologia, AOU Cagliari Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2120
    35
  • PO:10:155 | Etanercept-induced lupus in a patient with rheumatoid arthritis: diagnostic challenges and multidisciplinary therapeutic approach Camilla Riboldi1|2, Claudia Iannone1|2, Maria Gerosa1|2, Roberto Felice Caporali1|2 | 1ASST G. Pini-CTO, U.O.C. di Clinica Reumatologica, Milano; 2Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2149
    22
  • Diagnostic perspectives in the reumathological vasculitis: the role of the videocapillaroscopic analysis

    C. Pizzorni, A. Sulli, C. Craviotto, M. Tuccio, B. Seriolo, M. Cutolo
    99-104
    https://doi.org/10.4081/reumatismo.2002.99
    1078
    PDF: 1565
1 - 32 of 32 items
Make a Submission

authors

FOR AUTHORS
  • ARTICLE PROCESSING CHARGE
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review
  • Thanks to Reviewers

Categories

    • Abstract Book
    • Oral Communications - Day 1
    • Posters - Day 1
    • Oral Communications - Day 2
    • Posters - Day 2
    • Oral Communications - Day 3

indexing

INDEXING
  • PubMed
  • Scopus
  • Web of Science
  • Google Scholar
  • OpenAlex
  • Scilit
  • DOAJ
  • Analytics
  • Società Italiana di Reumatologia
Vol. 77 No. 4 (2025)
Rare in the rare: Kikuchi-Fujimoto disease associated with connective tissue disorders. A report of our experience
Carmela Coccia et al.
4 August 2025
Vol. 77 No. 4 (2025)
Paratenon effusion of the Achilles tendon: a rare finding
Raphael Micheroli et al.
1 September 2025
Vol. 77 No. 4 (2025)
The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus
Fulvia Ceccarelli et al.
23 July 2025
Vol. 77 No. 4 (2025)
The diagnostic utility of miRNA21 in systemic sclerosis
Gehad Gamal Maghraby et al.
25 September 2025

Keywords

Reumatismo - The Italian Journal of Rheumatology

is the Official Journal of the Italian Society of Rheumatology (SIR). Founded in 1949. Published online by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 0048-7449
eISSN: 2240-2683

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

Themes by Openjournaltheme.com

© PAGEPress 2008-2025    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy